Shares of Hospira (HSP) tumbled 2.81% to close the trading session on Aug 19 at $53.92 per share, following the company's decision to file a lawsuit against the FDA over approvals granted to generic ...

Hospira's reprieve from generic Precedex competition was short-lived. The U.S. district court that temporarily stopped Precedex generics has now decided to let the copycats roll. And that could mean ...

(Reuters) - A federal judge has issued a temporary restraining order against the U.S. Food and Drug Administration's decision to allow the sale of generic versions of the Hospira Inc sedative Precedex ...

Orion Corporation and Hospira, Inc. have extended their licensing agreement concerning the sedative agent Precedex® in the markets outside the Europe. Orion and Hospira (originally Abbott) have ...

To earn CME related to this news article, click here. January 2, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions for clofarabine injection, dexmedetomidine HCl ...

Dr. Reddy’ is offering dexmedetomidine hydrochloride in 0.9% sodium chloride injection. The product is the generic of Hospira’s Precedex (dexmedetomidine hydrochloride) in 0.9% Sodium Chloride ...

Dexmedetomidine HCl in 0.9% NaCl; 4mcg/mL; soln for IV infusion. Precedex (dexmedetomidine hydrochloride) injection 200 mcg/2 mL (100 mcg/mL) is clear and colorless. The strength is based on the ...

WOODCLIFF LAKE, N.J., Sept. 8, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has resumed shipping dexmedetomidine hydrochloride (HCl) injection, EQ 100 mcg base/mL, ...

Milla Pharmaceuticals has received the Food and Drug Administration’s blessing for generic Precedex (dexmedetomidine hydrochloride injection) 4 mcg/ml in 50 ml and 100 ml. The injection is indicated ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, a medication for ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...

The FDA has approved Precedex (dexmedetomidine HCl, from Hospira) injection for the sedation of non-intubated patients prior to and/or during surgical and other procedures. This approval is based on ...